Crystalline pharmaceutical co-crystals of glycopyrronium bromide with lactose

A technology of glycopyrronium bromide and lactose, which is applied in the field of co-crystallization of glycopyrronium bromide and lactose, can solve the problem of short time, such as 0.6 to 1.2 hours

Pending Publication Date: 2019-03-15
HOVIONE SCIENTIA
View PDF19 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Glycopyrrolate has a short half-life of 0.6 to 1.2 hours

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystalline pharmaceutical co-crystals of glycopyrronium bromide with lactose
  • Crystalline pharmaceutical co-crystals of glycopyrronium bromide with lactose
  • Crystalline pharmaceutical co-crystals of glycopyrronium bromide with lactose

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0113] Example 1-Preparation of the co-crystal of glycopyrrolate and lactose

[0114] Glycopyrrolate (2.0 g; 5.0 mmol) and lactose monohydrate (1.98 g; 5.49 mmol) were dissolved in dimethyl sulfoxide (DMSO) (10 ml) at a temperature of 50°C to 55°C. Then, while keeping the reaction mixture at a temperature of 50°C to 55°C, ethyl acetate (50 ml) was added dropwise.

[0115] A suspension is obtained, and the reaction mixture is cooled to a temperature of 20 to 25°C and kept at this temperature with stirring for 3 hours.

[0116] The product was filtered and washed with ethyl acetate, and then dried in vacuum at a temperature of 35°C to 40°C to obtain 3.7 g of a co-crystal of glycopyrrolate and lactose.

[0117] The product was analyzed using differential scanning calorimetry (DSC). XRPD results showed that a new crystal form was formed: a co-crystal of glycopyrrolate and lactose.

[0118] The XRPD and DSC of the eutectic are characterized in figure 1 with 2 Described as'GBr1' in.

Embodiment 2

[0119] Example 2-Preparation of co-crystal of glycopyrrolate and lactose

[0120] Glycopyrrolate (2.0 g; 5.0 mmol) and lactose monohydrate (1.98 g; 5.49 mmol) were dissolved in dimethylformamide (DMF) (10 ml) at a temperature of 50°C to 55°C. Then, while keeping the reaction mixture at a temperature of 50°C to 55°C, ethyl acetate (50 ml) was added dropwise.

[0121] A suspension was obtained, and the reaction mixture was cooled to a temperature of 20 to 25°C and kept at this temperature with stirring for 3 hours.

[0122] The product was filtered and washed with ethyl acetate, and then dried under vacuum at a temperature of 35°C to 40°C to obtain 3.83 g of a co-crystal of glycopyrrolate and lactose.

[0123] The product was analyzed using differential scanning calorimetry (DSC). XRPD results showed that a new crystal form was formed: a co-crystal of glycopyrrolate and lactose.

[0124] The XRPD and DSC of the eutectic are characterized in figure 1 with 2 It is described as'GBr2'.

Embodiment 3

[0125] Example 3 Preparation of co-crystal of glycopyrrolate and lactose

[0126] Glycopyrrolate (2.0 g; 5.0 mmol) and lactose monohydrate (1.98 g; 5.49 mmol) were dissolved in dimethylformamide (DMF) (40 ml) at a temperature of 50°C to 55°C. Then, while keeping the reaction mixture at a temperature of 50°C to 55°C, methyl ethyl ketone (MEK) (80 ml) was added dropwise.

[0127] A suspension is obtained, and the reaction mixture is cooled to a temperature of 20 to 25°C and kept at this temperature with stirring for 3 hours.

[0128] The product was filtered, washed with methyl ethyl ketone (MEK), and then dried in vacuum at a temperature of 35°C to 40°C to obtain 3.06 g of a co-crystal of glycopyrrolate and lactose.

[0129] The product was analyzed using differential scanning calorimetry (DSC). XRPD results showed that a new crystal form was formed: a co-crystal of glycopyrrolate and lactose.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides co-crystals of glycopyrronium bromide with lactose. The glycopyrronium bromide and lactose in the novel co-crystals are present in a stoichiometric ratio of from about 1:2 to 2: 1. These are characterized by XRD and DSC. Processes for preparing the novel co-crystals are also provided. The co-crystals are also disclosed for use as a medicament, in particular, for treatment of respiratory complaints, such as chronic pulmonary obstructive disease (COPD), bronchitis and asthma. Pharmaceutical compositions comprising the co-crystals as active ingredient are also presented.

Description

Technical field [0001] The present invention relates to a co-crystal of glycopyrrolate and lactose, a method for preparing the co-crystal, and its use as a medicine (especially a medicine for treating respiratory diseases, such as chronic obstructive pulmonary disease (COPD), bronchitis and asthma) use. The present invention also relates to a pharmaceutical composition comprising a co-crystal of glycopyrrolate as an active ingredient. Background technique [0002] Glycopyrronium bromide (Glycopyrronium bromide, also known as Glycopyrrolate bromide) is an antagonist of muscarinic receptors and is used to treat urinary incontinence (US6214792 and US5919760), salivation (Tscheng, Z.Ann. Pharmacother, 2002), hyperhidrosis Disease (US20100276329), overactive bladder and for preoperative treatment. It is also an anticholinergic bronchodilator and is used to treat asthma and chronic obstructive pulmonary disease (COPD). Antimuscarinic bronchodilators are generally considered to be mo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D207/12A61K31/40A61P13/06
CPCC07D207/12A61P11/00A61P11/06A61P13/06A61P29/00A61P43/00C07B2200/13C07H3/04
InventorZ·门德斯T·彭塞卡
OwnerHOVIONE SCIENTIA